fleroxacin has been researched along with Cross Infection in 3 studies
Fleroxacin: A broad-spectrum antimicrobial fluoroquinolone. The drug strongly inhibits the DNA-supercoiling activity of DNA GYRASE.
fleroxacin : A fluoroquinolone antibiotic that is 4-oxo-1,4-dihydroquinoline which is substituted at positions 1, 3, 6, 7 and 8 by 2-fluoroethyl, carboxy, fluoro, 4-methylpiperazin-1-yl and fluoro groups, respectively. It is active against many Gram-positive and Gram-negative bacteria.
Cross Infection: Any infection which a patient contracts in a health-care institution.
| Excerpt | Relevance | Reference |
|---|---|---|
| " The once daily dosage of fleroxacin [400 mg once daily intravenously (i." | 2.68 | Quinolones in everyday clinical practice: respiratory tract infections and nosocomial pneumonia. ( Marklein, G, 1996) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Sofianou, D | 1 |
| Frantzidou, F | 1 |
| Tsakris, A | 1 |
| Marklein, G | 1 |
| Araque, M | 1 |
| Velazco, E | 1 |
1 trial available for fleroxacin and Cross Infection
| Article | Year |
|---|---|
Quinolones in everyday clinical practice: respiratory tract infections and nosocomial pneumonia.
Topics: Adult; Aged; Anti-Infective Agents; Ciprofloxacin; Cross Infection; Double-Blind Method; Female; Fle | 1996 |
2 other studies available for fleroxacin and Cross Infection
| Article | Year |
|---|---|
Comparative in-vitro activity of fleroxacin against 480 nosocomial isolates.
Topics: Anti-Infective Agents; Cross Infection; Fleroxacin; Gram-Negative Bacteria; Gram-Positive Bacteria; | 1994 |
In vitro activity of fleroxacin against multiresistant gram-negative bacilli isolated from patients with nosocomial infections.
Topics: Adult; Anti-Infective Agents; Cross Infection; Drug Resistance, Microbial; Drug Resistance, Multiple | 1998 |